000 01198 a2200361 4500
005 20250512043133.0
264 0 _c19890803
008 198908s 0 0 eng d
022 _a0300-0664
024 7 _a10.1111/j.1365-2265.1988.tb01221.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArntzenius, A B
245 0 0 _aThe significance of the initial FT4-index for the management of single daily dose methimazole treatment of hyperthyroidism.
_h[electronic resource]
260 _bClinical endocrinology
_cSep 1988
300 _a239-47 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperthyroidism
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMethimazole
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aThyroxine
_xblood
650 0 4 _aTriiodothyronine
_xblood
700 1 _aElte, J W
700 1 _aFrölich, M
700 1 _aHaak, A
773 0 _tClinical endocrinology
_gvol. 29
_gno. 3
_gp. 239-47
856 4 0 _uhttps://doi.org/10.1111/j.1365-2265.1988.tb01221.x
_zAvailable from publisher's website
999 _c3257433
_d3257433